This author has yet to write their bio.Meanwhile lets just say that we are proud Sean Kelly contributed a whooping 75 entries.
Research Project information Principal researcher: Professor Zoya Ignatova (University of Hamburg) and Professor Grant Stewart (University of Birmingham) Institute: University of Hamburg and University of Birmingham Cost: £249,615 over 24 months in partnership with NATA (Nucleic Acid Therapy Accelerator), Oxford Start Date: 1st of June 2024 What are the researchers proposing to do? The underlying cause of Ataxia-Telangiectasia (A-T) […]
Research Project information Principal researcher: Professor Ignacio Molina & Dr García-Pérez Institute: University of Granada, Spain Cost: £100,000 (funded in partnership with AEFAT, Spain) Completion date: March 2024 Project Overview Gene therapy is a technique for correcting genetic defect by inserting a healthy copy of a gene into cells (replacing a faulty gene). To deliver a […]
Research Project information Principal researcher: Professor Margot Mayer-Proschel and Professor Michael O’Reilly Institute: University of Rochester, New York Cost: £246,691 over 36 months Completion date: March 2024 Project Overview A-T is a multi-organ disease, yet neurological pathologies (one of the main problems in A-T) are for the most part studied in isolation from other organs. Professors Mayer-Proschel […]
Research Project information Principal researcher: Dr Rob Dineen Institute: University of Nottingham Cost: £100,556.59 over 24 months Completion date: September 2023 Project Overview Dr Rob Dineen and his team believe that the combination of an MRI scan of the whole body together with a blood test is a good way to find hidden cancers in […]
Principal researcher: Professor Hilde L. Nilsen Institute: Oslo University Hospital, Norway Cost: €150.000 over 24 months in partnership with AEFAT (Spain) and BrAshA-T (Australia) Start Date: Jan 2024 What are the researchers proposing to do and why? This preclinical study utilizes an injection of Recombinant Adeno Associated Virus 9 (rAAV9) to deliver a therapeutic mini version […]
Principal researcher: Dr Núria Montserrat Institute: Institute for Bioengineering of Catalonia, Spain Cost: €150.000 over 24 months in partnership with AEFAT (Spain) and BrAshA-T (Australia) Start Date: Jan 2024 What are the researchers proposing to do and why? A-T is caused by mutations in the ATM gene. The most debilitating symptom of the condition is the […]
Trailblazers Walk – 15th June 2024
17th January 2024
Research Project information Principal researcher: Professor Mike Kastan Institute: Duke University, North Carolina, USA Cost: £249,854 over 36 months Completion date: 31st December 2023 Project Overview Ataxia Telangiectasia (A-T), results from loss of function of the ATM (Ataxia Telangiectasia, Mutated) gene. Although much is known about the function of the protein encoded by this gene, mechanistic understanding of how […]
Various dates 2025
20th September 2024
2023 Spotlight on A-T Webinar
Research Project information Principal researcher: Associate Professor Vincenzo Costanzo Institute: IFOM – The FIRC Institute of Molecular Oncology, Milan, Italy Cost: £125.820,50 over 36 months in partnership with the A-T Society (UK), AEFAT (Spain) and BrAshA-T (Australia) Start Date: 1st of April 2023 What are the researchers proposing to do? Costanzo and team will test the hypothesis that ATM […]
